ID   ENPP2_RAT               Reviewed;         887 AA.
AC   Q64610; Q66HQ0;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   02-OCT-2024, entry version 173.
DE   RecName: Full=Autotaxin {ECO:0000303|PubMed:16436050};
DE            EC=3.1.4.39 {ECO:0000269|PubMed:12119361, ECO:0000269|PubMed:12633853, ECO:0000269|PubMed:21240271, ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273, ECO:0000269|PubMed:27660691, ECO:0000269|PubMed:29259743};
DE            EC=3.1.4.4 {ECO:0000250|UniProtKB:Q13822};
DE   AltName: Full=Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 {ECO:0000312|RGD:69298};
DE            Short=E-NPP 2;
DE   AltName: Full=Extracellular lysophospholipase D;
DE            Short=LysoPLD {ECO:0000303|PubMed:12119361, ECO:0000303|PubMed:12354767};
DE   Flags: Precursor;
GN   Name=Enpp2 {ECO:0000312|RGD:69298}; Synonyms=Atx, Npps2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7961762; DOI=10.1016/s0021-9258(18)46919-0;
RA   Narita M., Goji J., Nakamura H., Sano K.;
RT   "Molecular cloning, expression, and localization of a brain-specific
RT   phosphodiesterase I/nucleotide pyrophosphatase (PD-Ialpha) from rat
RT   brain.";
RL   J. Biol. Chem. 269:28235-28242(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), PROTEIN SEQUENCE OF 28-32 AND
RP   36-41, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=16436050; DOI=10.1111/j.1365-2443.2006.00924.x;
RA   Koike S., Keino-Masu K., Ohto T., Masu M.;
RT   "The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as a
RT   signal peptide.";
RL   Genes Cells 11:133-142(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12176993; DOI=10.1074/jbc.m205623200;
RA   Tokumura A., Majima E., Kariya Y., Tominaga K., Kogure K., Yasuda K.,
RA   Fukuzawa K.;
RT   "Identification of human plasma lysophospholipase D, a lysophosphatidic
RT   acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase.";
RL   J. Biol. Chem. 277:39436-39442(2002).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=12354767; DOI=10.1074/jbc.m206812200;
RA   Aoki J., Taira A., Takanezawa Y., Kishi Y., Hama K., Kishimoto T.,
RA   Mizuno K., Saku K., Taguchi R., Arai H.;
RT   "Serum lysophosphatidic acid is produced through diverse phospholipase
RT   pathways.";
RL   J. Biol. Chem. 277:48737-48744(2002).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=12119361; DOI=10.1083/jcb.200204026;
RA   Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K., Yamori T.,
RA   Mills G.B., Inoue K., Aoki J., Arai H.;
RT   "Autotaxin has lysophospholipase D activity leading to tumor cell growth
RT   and motility by lysophosphatidic acid production.";
RL   J. Cell Biol. 158:227-233(2002).
RN   [7]
RP   CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, MUTAGENESIS OF ASP-171; THR-209;
RP   ASP-311 AND HIS-315, AND ACTIVE SITE.
RX   PubMed=12633853; DOI=10.1016/s0014-5793(03)00133-9;
RA   Gijsbers R., Aoki J., Arai H., Bollen M.;
RT   "The hydrolysis of lysophospholipids and nucleotides by autotaxin (NPP2)
RT   involves a single catalytic site.";
RL   FEBS Lett. 538:60-64(2003).
RN   [8]
RP   PROTEOLYTIC PROCESSING, PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION
RP   CHARACTERIZATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ILE-13;
RP   16-PHE--PHE-18; 18-PHE--SER-21; 21-SER--ILE-24; 24-ILE--CYS-25 AND
RP   28-PHE--ALA-30.
RX   PubMed=15985467; DOI=10.1242/jcs.02438;
RA   Jansen S., Stefan C., Creemers J.W., Waelkens E., Van Eynde A.,
RA   Stalmans W., Bollen M.;
RT   "Proteolytic maturation and activation of autotaxin (NPP2), a secreted
RT   metastasis-enhancing lysophospholipase D.";
RL   J. Cell Sci. 118:3081-3089(2005).
RN   [9]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=29259743; DOI=10.1021/acsmedchemlett.7b00312;
RA   Kuttruff C.A., Ferrara M., Bretschneider T., Hoerer S., Handschuh S.,
RA   Nosse B., Romig H., Nicklin P., Roth G.J.;
RT   "Discovery of BI-2545: A Novel Autotaxin Inhibitor That Significantly
RT   Reduces LPA Levels in Vivo.";
RL   ACS Med. Chem. Lett. 8:1252-1257(2017).
RN   [10] {ECO:0007744|PDB:2XR9, ECO:0007744|PDB:2XRG}
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 36-862 IN COMPLEX WITH INHIBITOR;
RP   CALCIUM AND ZINC IONS, CATALYTIC ACTIVITY, COFACTOR, CALCIUM BINDING,
RP   DISULFIDE BONDS, GLYCOSYLATION AT ASN-524, ACTIVE SITE, MUTAGENESIS OF
RP   LYS-430 AND 764-ASP--ASP-768, AND SUBCELLULAR LOCATION.
RX   PubMed=21240271; DOI=10.1038/nsmb.1980;
RA   Hausmann J., Kamtekar S., Christodoulou E., Day J.E., Wu T., Fulkerson Z.,
RA   Albers H.M., van Meeteren L.A., Houben A.J., van Zeijl L., Jansen S.,
RA   Andries M., Hall T., Pegg L.E., Benson T.E., Kasiem M., Harlos K.,
RA   Kooi C.W., Smyth S.S., Ovaa H., Bollen M., Morris A.J., Moolenaar W.H.,
RA   Perrakis A.;
RT   "Structural basis of substrate discrimination and integrin binding by
RT   autotaxin.";
RL   Nat. Struct. Mol. Biol. 18:198-204(2011).
RN   [11] {ECO:0007744|PDB:5L0B, ECO:0007744|PDB:5L0E, ECO:0007744|PDB:5L0K}
RP   X-RAY CRYSTALLOGRAPHY (2.41 ANGSTROMS) IN COMPLEX WITH INHIBITOR; CALCIUM
RP   AND ZINC, CATALYTIC ACTIVITY, COFACTOR, FUNCTION, GLYCOSYLATION AT ASN-410
RP   AND ASN-524, AND DISULFIDE BONDS.
RX   PubMed=27660691; DOI=10.1021/acsmedchemlett.6b00207;
RA   Jones S.B., Pfeifer L.A., Bleisch T.J., Beauchamp T.J., Durbin J.D.,
RA   Klimkowski V.J., Hughes N.E., Rito C.J., Dao Y., Gruber J.M., Bui H.,
RA   Chambers M.G., Chandrasekhar S., Lin C., McCann D.J., Mudra D.R.,
RA   Oskins J.L., Swearingen C.A., Thirunavukkarasu K., Norman B.H.;
RT   "Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead
RT   Optimization via Structure-Based Drug Design.";
RL   ACS Med. Chem. Lett. 7:857-861(2016).
RN   [12] {ECO:0007744|PDB:5IJQ, ECO:0007744|PDB:5IJS}
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 36-887 IN COMPLEXES WITH
RP   PHOSPHATE; VANADATE; HYDROXYCHOLESTEROL; CALCIUM AND ZINC, FUNCTION,
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, COFACTOR, ACTIVE SITE,
RP   GLYCOSYLATION AT ASN-524, AND DISULFIDE BONDS.
RX   PubMed=27268273; DOI=10.1016/j.jsb.2016.06.002;
RA   Hausmann J., Keune W.J., Hipgrave Ederveen A.L., van Zeijl L.,
RA   Joosten R.P., Perrakis A.;
RT   "Structural snapshots of the catalytic cycle of the phosphodiesterase
RT   Autotaxin.";
RL   J. Struct. Biol. 195:199-206(2016).
RN   [13] {ECO:0007744|PDB:5DLT, ECO:0007744|PDB:5DLV, ECO:0007744|PDB:5DLW}
RP   X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF 36-887 IN COMPLEXES WITH OLEOYL
RP   LYSOPHOSPHATIDIC ACID; STEROIDS; CALCIUM AND ZINC, CATALYTIC ACTIVITY,
RP   FUNCTION, ACTIVITY REGULATION, COFACTOR, GLYCOSYLATION AT ASN-524, AND
RP   DISULFIDE BONDS.
RX   PubMed=27075612; DOI=10.1038/ncomms11248;
RA   Keune W.J., Hausmann J., Bolier R., Tolenaars D., Kremer A.,
RA   Heidebrecht T., Joosten R.P., Sunkara M., Morris A.J., Matas-Rico E.,
RA   Moolenaar W.H., Oude Elferink R.P., Perrakis A.;
RT   "Steroid binding to Autotaxin links bile salts and lysophosphatidic acid
RT   signalling.";
RL   Nat. Commun. 7:11248-11248(2016).
CC   -!- FUNCTION: Secreted lysophospholipase D that hydrolyzes
CC       lysophospholipids to produce the signaling molecule lysophosphatidic
CC       acid (LPA) in extracellular fluids (PubMed:12354767, PubMed:12633853,
CC       PubMed:27075612, PubMed:27268273, PubMed:27660691, PubMed:29259743).
CC       Its major substrate is lysophosphatidylcholine (PubMed:12119361,
CC       PubMed:12176993, PubMed:27075612, PubMed:27268273, PubMed:27660691).
CC       Can also act on sphingosylphosphorylcholine producing sphingosine-1-
CC       phosphate, a modulator of cell motility (PubMed:12119361). Can
CC       hydrolyze, in vitro, bis-pNPP, to some extent pNP-TMP, and barely ATP
CC       (PubMed:12633853, PubMed:27268273). Involved in several motility-
CC       related processes such as angiogenesis and neurite outgrowth. Acts as
CC       an angiogenic factor by stimulating migration of smooth muscle cells
CC       and microtubule formation. Stimulates migration of melanoma cells,
CC       probably via a pertussis toxin-sensitive G protein. May have a role in
CC       induction of parturition. Possible involvement in cell proliferation
CC       and adipose tissue development (By similarity). Required for LPA
CC       production in activated platelets, cleaves the sn-1 lysophospholipids
CC       to generate sn-1 lysophosphatidic acids containing predominantly 18:2
CC       and 20:4 fatty acids (By similarity). Shows a preference for the sn-1
CC       to the sn-2 isomer of 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF)
CC       (By similarity). {ECO:0000250|UniProtKB:Q13822,
CC       ECO:0000269|PubMed:12119361, ECO:0000269|PubMed:12176993,
CC       ECO:0000269|PubMed:12354767, ECO:0000269|PubMed:12633853,
CC       ECO:0000269|PubMed:15985467, ECO:0000269|PubMed:27075612,
CC       ECO:0000269|PubMed:27268273, ECO:0000269|PubMed:27660691,
CC       ECO:0000269|PubMed:29259743}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-alkyl-sn-glycero-3-phosphoethanolamine + H2O = 1-O-alkyl-
CC         sn-glycero-3-phosphate + ethanolamine + H(+); Xref=Rhea:RHEA:15965,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57603,
CC         ChEBI:CHEBI:58014, ChEBI:CHEBI:76168; EC=3.1.4.39;
CC         Evidence={ECO:0000269|PubMed:12119361, ECO:0000269|PubMed:12633853,
CC         ECO:0000269|PubMed:21240271, ECO:0000269|PubMed:27075612,
CC         ECO:0000269|PubMed:27268273, ECO:0000269|PubMed:27660691,
CC         ECO:0000269|PubMed:29259743};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphoethanolamine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphate + ethanolamine + H(+); Xref=Rhea:RHEA:39003,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57603,
CC         ChEBI:CHEBI:57970, ChEBI:CHEBI:64381;
CC         Evidence={ECO:0000269|PubMed:12354767};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39004;
CC         Evidence={ECO:0000305|PubMed:12354767};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphoethanolamine + H2O =
CC         1-(9Z-octadecenoyl)-sn-glycero-3-phosphate + ethanolamine + H(+);
CC         Xref=Rhea:RHEA:38927, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57603, ChEBI:CHEBI:74544, ChEBI:CHEBI:74971;
CC         Evidence={ECO:0000269|PubMed:12354767};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38928;
CC         Evidence={ECO:0000305|PubMed:12354767};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-alkyl-sn-glycero-3-phosphocholine + H2O = 1-O-alkyl-sn-
CC         glycero-3-phosphate + choline + H(+); Xref=Rhea:RHEA:39927,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30909, ChEBI:CHEBI:58014;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39928;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-(9Z-octadecenyl)-sn-glycero-3-phosphocholine + H2O = 1-O-
CC         (9Z-octadecenyl)-sn-glycero-3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:41684, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:64396, ChEBI:CHEBI:78402;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41685;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-sn-glycero-3-phosphocholine + H2O = 1-O-
CC         hexadecyl-sn-glycero-3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:41143, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:64496, ChEBI:CHEBI:77580;
CC         Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41144;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-(1Z-alkenyl)-sn-glycero-3-phosphocholine + H2O = 1-O-(1Z-
CC         alkenyl)-sn-glycero-3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:41588, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:77283, ChEBI:CHEBI:77287;
CC         Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41589;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphate + choline + H(+); Xref=Rhea:RHEA:38995,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57970, ChEBI:CHEBI:58168; EC=3.1.4.4;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38996;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-dodecanoyl-sn-glycero-3-phosphocholine + H2O = 1-dodecanoyl-
CC         sn-glycerol 3-phosphate + choline + H(+); Xref=Rhea:RHEA:38991,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:72682, ChEBI:CHEBI:74966;
CC         Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38992;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine + H2O = 1-(9Z-
CC         octadecenoyl)-sn-glycero-3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:38915, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28610, ChEBI:CHEBI:74544;
CC         Evidence={ECO:0000269|PubMed:12176993, ECO:0000269|PubMed:12354767};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38916;
CC         Evidence={ECO:0000305|PubMed:12176993, ECO:0000305|PubMed:12354767};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-tetradecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         tetradecanoyl-sn-glycerol 3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:38983, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:64489, ChEBI:CHEBI:72683;
CC         Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38984;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-decanoyl-sn-glycero-3-phosphocholine + H2O = 1-decanoyl-sn-
CC         glycero-3-phosphate + choline + H(+); Xref=Rhea:RHEA:41131,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:77724, ChEBI:CHEBI:77726;
CC         Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41132;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-octadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         octadecanoyl-sn-glycero-3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:38979, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:73858, ChEBI:CHEBI:74565;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38980;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexadecanoyl-sn-glycero-3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:38975, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:57518, ChEBI:CHEBI:72998;
CC         Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38976;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexanoyl-sn-glycero-3-phosphocholine + H2O = 1-hexanoyl-sn-
CC         glycero-3-phosphate + choline + H(+); Xref=Rhea:RHEA:41400,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:78215, ChEBI:CHEBI:78223;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41401;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z,12Z)-octadecadienoyl-sn-glycero-3-phosphocholine + H2O =
CC         1-(9Z,12Z)-octadecadienoyl-sn-glycero-3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:41135, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:28733, ChEBI:CHEBI:74547;
CC         Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41136;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + sphing-4-enine-phosphocholine = choline + H(+) + sphing-
CC         4-enine 1-phosphate; Xref=Rhea:RHEA:38919, ChEBI:CHEBI:15354,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58906,
CC         ChEBI:CHEBI:60119; Evidence={ECO:0000250|UniProtKB:Q13822};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38920;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine
CC         + H2O = 1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphate +
CC         choline + H(+); Xref=Rhea:RHEA:41139, ChEBI:CHEBI:15354,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:74344,
CC         ChEBI:CHEBI:74938; Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41140;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2-acyl-sn-glycero-3-phosphocholine + H2O = a 2-acyl-sn-
CC         glycerol 3-phosphate + choline + H(+); Xref=Rhea:RHEA:41712,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57875, ChEBI:CHEBI:64982;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41713;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1,2-diacyl-
CC         sn-glycero-3-phosphate + choline + H(+); Xref=Rhea:RHEA:14445,
CC         ChEBI:CHEBI:15354, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:57643, ChEBI:CHEBI:58608; EC=3.1.4.4;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14446;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-dioctanoyl-sn-glycero-3-phosphocholine + H2O = 1,2-
CC         dioctanoyl-sn-glycero-3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:41416, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:78228, ChEBI:CHEBI:78229;
CC         Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41417;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1,2-didecanoyl-sn-glycero-3-phosphocholine + H2O = 1,2-
CC         didecanoyl-sn-glycero-3-phosphate + choline + H(+);
CC         Xref=Rhea:RHEA:41412, ChEBI:CHEBI:15354, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:78226, ChEBI:CHEBI:78227;
CC         Evidence={ECO:0000269|PubMed:12176993};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41413;
CC         Evidence={ECO:0000305|PubMed:12176993};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1-acyl-sn-glycero-3-phospho-L-serine + H2O = a 1-acyl-sn-
CC         glycero-3-phosphate + H(+) + L-serine; Xref=Rhea:RHEA:38999,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:33384,
CC         ChEBI:CHEBI:57970, ChEBI:CHEBI:64379;
CC         Evidence={ECO:0000269|PubMed:12354767};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39000;
CC         Evidence={ECO:0000305|PubMed:12354767};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(9Z-octadecenoyl)-sn-glycero-3-phospho-L-serine + H2O = 1-
CC         (9Z-octadecenoyl)-sn-glycero-3-phosphate + H(+) + L-serine;
CC         Xref=Rhea:RHEA:38931, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:33384, ChEBI:CHEBI:74544, ChEBI:CHEBI:74617;
CC         Evidence={ECO:0000269|PubMed:12354767};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38932;
CC         Evidence={ECO:0000305|PubMed:12354767};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2-acyl-sn-glycero-3-phospho-L-serine + H2O = a 2-acyl-sn-
CC         glycerol 3-phosphate + H(+) + L-serine; Xref=Rhea:RHEA:41716,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:33384,
CC         ChEBI:CHEBI:64982, ChEBI:CHEBI:65214;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41717;
CC         Evidence={ECO:0000250|UniProtKB:Q13822};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:21240271, ECO:0000269|PubMed:27075612,
CC         ECO:0000269|PubMed:27268273};
CC       Note=Binds 2 Zn(2+) ions per subunit. {ECO:0000269|PubMed:21240271,
CC       ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:21240271, ECO:0000269|PubMed:27075612,
CC         ECO:0000269|PubMed:27268273};
CC       Note=Binds 1 Ca(2+) ion per subunit. {ECO:0000269|PubMed:21240271,
CC       ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273};
CC   -!- ACTIVITY REGULATION: Inhibited by vanadate (PubMed:27268273). Inhibited
CC       by micromolar levels of bile salts, such as tauroursodeoxycholate. Not
CC       inhibited by taurodeoxycholate. Not inhibited by hydroxysterols, such
CC       as 7-hydroxycholesterol, testosterone, dexamethasone and prednisolone
CC       (PubMed:27075612). Inhibited by EDTA and EGTA (PubMed:12354767).
CC       {ECO:0000269|PubMed:12354767, ECO:0000269|PubMed:27075612,
CC       ECO:0000269|PubMed:27268273}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:12119361,
CC       ECO:0000269|PubMed:12633853, ECO:0000269|PubMed:15985467,
CC       ECO:0000269|PubMed:16436050, ECO:0000269|PubMed:21240271}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q64610-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q64610-2; Sequence=VSP_024018;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in cerebrum and cerebellum.
CC       Localized in secretory epithelial cells in the brain and the eye
CC       including choroid plexus epithelial cells, ciliary epithelial cells,
CC       iris pigment epithelial cells, and retinal pigment cells.
CC       {ECO:0000269|PubMed:16436050, ECO:0000269|PubMed:7961762}.
CC   -!- DOMAIN: The nuclease-like domain is most probably catalytically
CC       inactive as residues that are essential for catalysis in the DNA/RNA
CC       non-specific endonucleases are not conserved. However, it is required
CC       for the stability of the protein and the catalytic activity born by the
CC       Phosphodiesterase domain. {ECO:0000250|UniProtKB:Q9R1E6}.
CC   -!- PTM: N-glycosylation, but not furin-cleavage, plays a critical role on
CC       secretion and on lysoPLD activity. {ECO:0000250|UniProtKB:Q9R1E6}.
CC   -!- PTM: The interdomain disulfide bond between Cys-413 and Cys-830 is
CC       essential for catalytic activity. {ECO:0000250|UniProtKB:Q9R1E6}.
CC   -!- SIMILARITY: Belongs to the nucleotide pyrophosphatase/phosphodiesterase
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D28560; BAA05910.1; -; mRNA.
DR   EMBL; DQ131564; AAZ99725.1; -; mRNA.
DR   EMBL; BC081747; AAH81747.1; -; mRNA.
DR   PIR; A55453; A55453.
DR   RefSeq; NP_476445.2; NM_057104.2.
DR   PDB; 2XR9; X-ray; 2.05 A; A=36-887.
DR   PDB; 2XRG; X-ray; 3.20 A; A=1-887.
DR   PDB; 5DLT; X-ray; 1.60 A; A=36-887.
DR   PDB; 5DLV; X-ray; 2.00 A; A/B=36-887.
DR   PDB; 5DLW; X-ray; 1.80 A; A=36-887.
DR   PDB; 5IJQ; X-ray; 2.05 A; A=36-887.
DR   PDB; 5IJS; X-ray; 2.20 A; A=36-887.
DR   PDB; 5L0B; X-ray; 2.41 A; A/B=1-887.
DR   PDB; 5L0E; X-ray; 3.06 A; A/B=1-887.
DR   PDB; 5L0K; X-ray; 2.73 A; A/B=51-884.
DR   PDB; 5LQQ; X-ray; 2.40 A; A=36-887.
DR   PDB; 5M0D; X-ray; 2.40 A; A=36-887.
DR   PDB; 5M0E; X-ray; 1.95 A; A=36-887.
DR   PDB; 5M0M; X-ray; 2.10 A; A=36-887.
DR   PDB; 5M0S; X-ray; 2.10 A; A=36-887.
DR   PDB; 5S9L; X-ray; 1.90 A; A=28-887.
DR   PDB; 5S9M; X-ray; 1.80 A; A=28-887.
DR   PDB; 5S9N; X-ray; 1.80 A; A=28-887.
DR   PDB; 7P0K; X-ray; 2.20 A; AAA=56-884.
DR   PDB; 7P4J; X-ray; 1.79 A; A=36-887.
DR   PDB; 7P4O; X-ray; 1.69 A; A=36-887.
DR   PDB; 7Z0N; X-ray; 2.40 A; AAA=56-885.
DR   PDB; 7Z3K; X-ray; 2.00 A; AAA=56-885.
DR   PDB; 7Z3L; X-ray; 2.40 A; AAA=56-885.
DR   PDB; 8C4W; X-ray; 1.95 A; A=1-887.
DR   PDB; 8C7R; X-ray; 2.53 A; A=1-887.
DR   PDBsum; 2XR9; -.
DR   PDBsum; 2XRG; -.
DR   PDBsum; 5DLT; -.
DR   PDBsum; 5DLV; -.
DR   PDBsum; 5DLW; -.
DR   PDBsum; 5IJQ; -.
DR   PDBsum; 5IJS; -.
DR   PDBsum; 5L0B; -.
DR   PDBsum; 5L0E; -.
DR   PDBsum; 5L0K; -.
DR   PDBsum; 5LQQ; -.
DR   PDBsum; 5M0D; -.
DR   PDBsum; 5M0E; -.
DR   PDBsum; 5M0M; -.
DR   PDBsum; 5M0S; -.
DR   PDBsum; 5S9L; -.
DR   PDBsum; 5S9M; -.
DR   PDBsum; 5S9N; -.
DR   PDBsum; 7P0K; -.
DR   PDBsum; 7P4J; -.
DR   PDBsum; 7P4O; -.
DR   PDBsum; 7Z0N; -.
DR   PDBsum; 7Z3K; -.
DR   PDBsum; 7Z3L; -.
DR   PDBsum; 8C4W; -.
DR   PDBsum; 8C7R; -.
DR   AlphaFoldDB; Q64610; -.
DR   SMR; Q64610; -.
DR   STRING; 10116.ENSRNOP00000047118; -.
DR   BindingDB; Q64610; -.
DR   ChEMBL; CHEMBL3826870; -.
DR   GuidetoPHARMACOLOGY; 2901; -.
DR   SwissLipids; SLP:000000394; -.
DR   GlyCosmos; Q64610; 6 sites, No reported glycans.
DR   GlyGen; Q64610; 6 sites.
DR   iPTMnet; Q64610; -.
DR   PhosphoSitePlus; Q64610; -.
DR   Ensembl; ENSRNOT00000101657.1; ENSRNOP00000076476.1; ENSRNOG00000004089.8. [Q64610-1]
DR   Ensembl; ENSRNOT00055037493; ENSRNOP00055030577; ENSRNOG00055021831. [Q64610-1]
DR   Ensembl; ENSRNOT00060005237; ENSRNOP00060003873; ENSRNOG00060003167. [Q64610-1]
DR   Ensembl; ENSRNOT00065024767; ENSRNOP00065019351; ENSRNOG00065014947. [Q64610-1]
DR   GeneID; 84050; -.
DR   KEGG; rno:84050; -.
DR   UCSC; RGD:69298; rat. [Q64610-1]
DR   AGR; RGD:69298; -.
DR   CTD; 5168; -.
DR   RGD; 69298; Enpp2.
DR   GeneTree; ENSGT00940000155778; -.
DR   InParanoid; Q64610; -.
DR   OrthoDB; 1366859at2759; -.
DR   PhylomeDB; Q64610; -.
DR   BRENDA; 3.1.4.39; 5301.
DR   SABIO-RK; Q64610; -.
DR   EvolutionaryTrace; Q64610; -.
DR   PRO; PR:Q64610; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0047391; F:alkylglycerophosphoethanolamine phosphodiesterase activity; IDA:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0004622; F:lysophospholipase activity; IDA:UniProtKB.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0004528; F:phosphodiesterase I activity; IMP:RGD.
DR   GO; GO:0004630; F:phospholipase D activity; IEA:RHEA.
DR   GO; GO:0030247; F:polysaccharide binding; IEA:InterPro.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0060326; P:cell chemotaxis; IMP:RGD.
DR   GO; GO:0071276; P:cellular response to cadmium ion; IEP:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:RGD.
DR   GO; GO:0034638; P:phosphatidylcholine catabolic process; IDA:UniProtKB.
DR   GO; GO:0009395; P:phospholipid catabolic process; ISO:RGD.
DR   GO; GO:0006644; P:phospholipid metabolic process; ISO:RGD.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IDA:RGD.
DR   GO; GO:0010634; P:positive regulation of epithelial cell migration; ISO:RGD.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; IDA:RGD.
DR   GO; GO:2000394; P:positive regulation of lamellipodium morphogenesis; ISO:RGD.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; IDA:RGD.
DR   GO; GO:0050731; P:positive regulation of peptidyl-tyrosine phosphorylation; ISO:RGD.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IDA:RGD.
DR   GO; GO:0030334; P:regulation of cell migration; ISO:RGD.
DR   GO; GO:1903165; P:response to polycyclic arene; IEP:RGD.
DR   GO; GO:0030149; P:sphingolipid catabolic process; ISS:UniProtKB.
DR   CDD; cd16018; Enpp; 1.
DR   CDD; cd00091; NUC; 1.
DR   Gene3D; 4.10.410.20; -; 2.
DR   Gene3D; 3.40.720.10; Alkaline Phosphatase, subunit A; 1.
DR   Gene3D; 3.40.570.10; Extracellular Endonuclease, subunit A; 1.
DR   InterPro; IPR017850; Alkaline_phosphatase_core_sf.
DR   InterPro; IPR001604; DNA/RNA_non-sp_Endonuclease.
DR   InterPro; IPR044929; DNA/RNA_non-sp_Endonuclease_sf.
DR   InterPro; IPR020821; Extracellular_endonuc_su_A.
DR   InterPro; IPR044925; His-Me_finger_sf.
DR   InterPro; IPR002591; Phosphodiest/P_Trfase.
DR   InterPro; IPR020436; SMB_chordata.
DR   InterPro; IPR036024; Somatomedin_B-like_dom_sf.
DR   InterPro; IPR001212; Somatomedin_B_dom.
DR   PANTHER; PTHR10151; ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE; 1.
DR   PANTHER; PTHR10151:SF21; ECTONUCLEOTIDE PYROPHOSPHATASE_PHOSPHODIESTERASE FAMILY MEMBER 2; 1.
DR   Pfam; PF01223; Endonuclease_NS; 1.
DR   Pfam; PF01663; Phosphodiest; 1.
DR   Pfam; PF01033; Somatomedin_B; 2.
DR   PRINTS; PR00022; SOMATOMEDINB.
DR   SMART; SM00892; Endonuclease_NS; 1.
DR   SMART; SM00477; NUC; 1.
DR   SMART; SM00201; SO; 2.
DR   SUPFAM; SSF53649; Alkaline phosphatase-like; 1.
DR   SUPFAM; SSF54060; His-Me finger endonucleases; 1.
DR   SUPFAM; SSF90188; Somatomedin B domain; 2.
DR   PROSITE; PS00524; SMB_1; 2.
DR   PROSITE; PS50958; SMB_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Chemotaxis;
KW   Cleavage on pair of basic residues; Direct protein sequencing;
KW   Disulfide bond; Glycoprotein; Hydrolase; Lipid degradation;
KW   Lipid metabolism; Metal-binding; Obesity; Reference proteome; Repeat;
KW   Secreted; Signal; Zinc.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000269|PubMed:15985467,
FT                   ECO:0000269|PubMed:16436050"
FT   PROPEP          28..35
FT                   /note="Removed by furin"
FT                   /evidence="ECO:0000269|PubMed:15985467,
FT                   ECO:0000269|PubMed:16436050"
FT                   /id="PRO_0000281651"
FT   CHAIN           36..887
FT                   /note="Autotaxin"
FT                   /id="PRO_0000188569"
FT   DOMAIN          54..97
FT                   /note="SMB 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   DOMAIN          98..142
FT                   /note="SMB 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350"
FT   REGION          144..501
FT                   /note="Phosphodiesterase"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   REGION          586..615
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          622..887
FT                   /note="Nuclease-like domain"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   REGION          854..875
FT                   /note="Required for secretion"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   MOTIF           126..128
FT                   /note="Cell attachment site"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        209
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000269|PubMed:12633853,
FT                   ECO:0000269|PubMed:27268273"
FT   BINDING         171
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0000269|PubMed:27660691, ECO:0007744|PDB:2XR9,
FT                   ECO:0007744|PDB:2XRG, ECO:0007744|PDB:5DLT,
FT                   ECO:0007744|PDB:5DLV, ECO:0007744|PDB:5DLW,
FT                   ECO:0007744|PDB:5IJQ, ECO:0007744|PDB:5IJS,
FT                   ECO:0007744|PDB:5L0B, ECO:0007744|PDB:5L0E,
FT                   ECO:0007744|PDB:5L0K, ECO:0007744|PDB:5LQQ"
FT   BINDING         209
FT                   /ligand="1-(9Z-octadecenoyl)-sn-glycero-3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:74544"
FT                   /evidence="ECO:0007744|PDB:5DLW"
FT   BINDING         209
FT                   /ligand="1-hexadecanoyl-sn-glycero-3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57518"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         209
FT                   /ligand="1-tetradecanoyl-sn-glycerol 3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:72683"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         209
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0000269|PubMed:27660691, ECO:0007744|PDB:2XR9,
FT                   ECO:0007744|PDB:2XRG, ECO:0007744|PDB:5DLT,
FT                   ECO:0007744|PDB:5DLV, ECO:0007744|PDB:5DLW,
FT                   ECO:0007744|PDB:5IJQ, ECO:0007744|PDB:5IJS,
FT                   ECO:0007744|PDB:5L0B, ECO:0007744|PDB:5L0E,
FT                   ECO:0007744|PDB:5L0K, ECO:0007744|PDB:5LQQ"
FT   BINDING         230
FT                   /ligand="1-(9Z-octadecenoyl)-sn-glycero-3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:74544"
FT                   /evidence="ECO:0007744|PDB:5DLW"
FT   BINDING         230
FT                   /ligand="1-hexadecanoyl-sn-glycero-3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57518"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         230
FT                   /ligand="1-tetradecanoyl-sn-glycerol 3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:72683"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         311
FT                   /ligand="1-(9Z-octadecenoyl)-sn-glycero-3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:74544"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         311
FT                   /ligand="1-hexadecanoyl-sn-glycero-3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57518"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         311
FT                   /ligand="1-tetradecanoyl-sn-glycerol 3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:72683"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         311
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0000269|PubMed:27660691, ECO:0007744|PDB:2XR9,
FT                   ECO:0007744|PDB:2XRG, ECO:0007744|PDB:5DLT,
FT                   ECO:0007744|PDB:5DLV, ECO:0007744|PDB:5DLW,
FT                   ECO:0007744|PDB:5IJQ, ECO:0007744|PDB:5IJS,
FT                   ECO:0007744|PDB:5L0B, ECO:0007744|PDB:5L0E,
FT                   ECO:0007744|PDB:5L0K, ECO:0007744|PDB:5LQQ"
FT   BINDING         315
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0000269|PubMed:27660691, ECO:0007744|PDB:2XR9,
FT                   ECO:0007744|PDB:2XRG, ECO:0007744|PDB:5DLT,
FT                   ECO:0007744|PDB:5DLV, ECO:0007744|PDB:5DLW,
FT                   ECO:0007744|PDB:5IJQ, ECO:0007744|PDB:5IJS,
FT                   ECO:0007744|PDB:5L0B, ECO:0007744|PDB:5L0E,
FT                   ECO:0007744|PDB:5L0K, ECO:0007744|PDB:5LQQ"
FT   BINDING         358
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0000269|PubMed:27660691, ECO:0007744|PDB:2XRG,
FT                   ECO:0007744|PDB:5DLT, ECO:0007744|PDB:5DLV,
FT                   ECO:0007744|PDB:5IJS, ECO:0007744|PDB:5L0B,
FT                   ECO:0007744|PDB:5L0E, ECO:0007744|PDB:5L0K,
FT                   ECO:0007744|PDB:5LQQ"
FT   BINDING         359
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0000269|PubMed:27660691, ECO:0007744|PDB:2XR9,
FT                   ECO:0007744|PDB:2XRG, ECO:0007744|PDB:5DLT,
FT                   ECO:0007744|PDB:5DLV, ECO:0007744|PDB:5DLW,
FT                   ECO:0007744|PDB:5IJQ, ECO:0007744|PDB:5IJS,
FT                   ECO:0007744|PDB:5L0B, ECO:0007744|PDB:5L0E,
FT                   ECO:0007744|PDB:5L0K, ECO:0007744|PDB:5LQQ"
FT   BINDING         474
FT                   /ligand="1-(9Z-octadecenoyl)-sn-glycero-3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:74544"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         474
FT                   /ligand="1-hexadecanoyl-sn-glycero-3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:57518"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         474
FT                   /ligand="1-tetradecanoyl-sn-glycerol 3-phosphate"
FT                   /ligand_id="ChEBI:CHEBI:72683"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   BINDING         474
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0000269|PubMed:27660691, ECO:0007744|PDB:2XR9,
FT                   ECO:0007744|PDB:2XRG, ECO:0007744|PDB:5DLT,
FT                   ECO:0007744|PDB:5DLV, ECO:0007744|PDB:5DLW,
FT                   ECO:0007744|PDB:5IJQ, ECO:0007744|PDB:5IJS,
FT                   ECO:0007744|PDB:5L0B, ECO:0007744|PDB:5L0E,
FT                   ECO:0007744|PDB:5L0K, ECO:0007744|PDB:5LQQ"
FT   BINDING         764
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0007744|PDB:2XR9, ECO:0007744|PDB:2XRG,
FT                   ECO:0007744|PDB:5DLT, ECO:0007744|PDB:5DLV,
FT                   ECO:0007744|PDB:5DLW, ECO:0007744|PDB:5IJQ,
FT                   ECO:0007744|PDB:5L0K, ECO:0007744|PDB:5LQQ"
FT   BINDING         766
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0007744|PDB:2XR9, ECO:0007744|PDB:2XRG,
FT                   ECO:0007744|PDB:5DLT, ECO:0007744|PDB:5DLV,
FT                   ECO:0007744|PDB:5DLW, ECO:0007744|PDB:5IJQ,
FT                   ECO:0007744|PDB:5IJS, ECO:0007744|PDB:5L0K,
FT                   ECO:0007744|PDB:5LQQ"
FT   BINDING         768
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0007744|PDB:2XR9, ECO:0007744|PDB:2XRG,
FT                   ECO:0007744|PDB:5DLT, ECO:0007744|PDB:5DLV,
FT                   ECO:0007744|PDB:5DLW, ECO:0007744|PDB:5IJQ,
FT                   ECO:0007744|PDB:5IJS, ECO:0007744|PDB:5L0K,
FT                   ECO:0007744|PDB:5LQQ"
FT   BINDING         770
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0007744|PDB:2XR9, ECO:0007744|PDB:2XRG,
FT                   ECO:0007744|PDB:5DLT, ECO:0007744|PDB:5DLV,
FT                   ECO:0007744|PDB:5DLW, ECO:0007744|PDB:5IJQ,
FT                   ECO:0007744|PDB:5IJS, ECO:0007744|PDB:5L0K"
FT   BINDING         772
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /evidence="ECO:0000269|PubMed:21240271,
FT                   ECO:0000269|PubMed:27075612, ECO:0000269|PubMed:27268273,
FT                   ECO:0007744|PDB:2XR9, ECO:0007744|PDB:2XRG,
FT                   ECO:0007744|PDB:5DLT, ECO:0007744|PDB:5DLV,
FT                   ECO:0007744|PDB:5DLW, ECO:0007744|PDB:5IJQ,
FT                   ECO:0007744|PDB:5IJS, ECO:0007744|PDB:5L0K,
FT                   ECO:0007744|PDB:5LQQ"
FT   SITE            877
FT                   /note="Essential for catalytic activity"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R1E6"
FT   CARBOHYD        53
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        398
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        410
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        524
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:21240271"
FT   CARBOHYD        610
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        831
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        58..75
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        62..93
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        73..86
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        79..85
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        102..119
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        107..137
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        117..130
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        123..129
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        148..194
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        156..350
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        366..468
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        413..830
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        566..691
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        568..676
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   DISULFID        799..809
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00350,
FT                   ECO:0000269|PubMed:21240271"
FT   VAR_SEQ         591..615
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:16436050"
FT                   /id="VSP_024018"
FT   MUTAGEN         13
FT                   /note="I->L: No effect on secretion."
FT                   /evidence="ECO:0000269|PubMed:15985467"
FT   MUTAGEN         16..18
FT                   /note="FTF->VLS: No effect on secretion."
FT                   /evidence="ECO:0000269|PubMed:15985467"
FT   MUTAGEN         18..21
FT                   /note="FAIS->SVCV: No effect on secretion."
FT                   /evidence="ECO:0000269|PubMed:15985467"
FT   MUTAGEN         21..24
FT                   /note="SVNI->VLTT: No effect on secretion."
FT                   /evidence="ECO:0000269|PubMed:15985467"
FT   MUTAGEN         24..25
FT                   /note="IC->TI: No effect on secretion."
FT                   /evidence="ECO:0000269|PubMed:15985467"
FT   MUTAGEN         28..30
FT                   /note="FTA->CIF: No effect on secretion."
FT                   /evidence="ECO:0000269|PubMed:15985467"
FT   MUTAGEN         171
FT                   /note="D->N: Abolishes lysophospholipase D activity."
FT                   /evidence="ECO:0000269|PubMed:12633853"
FT   MUTAGEN         209
FT                   /note="T->A: Abolishes lysophospholipase D activity."
FT                   /evidence="ECO:0000269|PubMed:12633853"
FT   MUTAGEN         209
FT                   /note="T->S: 15% of wild-type lysophospholipase D
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:12633853"
FT   MUTAGEN         311
FT                   /note="D->N: Abolishes lysophospholipase D activity."
FT                   /evidence="ECO:0000269|PubMed:12633853"
FT   MUTAGEN         315
FT                   /note="H->Q: 20% of wild-type lysophospholipase D
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:12633853"
FT   MUTAGEN         430
FT                   /note="K->A: Impaired secretion. No effect on
FT                   lysophospholipase activity."
FT                   /evidence="ECO:0000269|PubMed:21240271"
FT   MUTAGEN         764..768
FT                   /note="DYNYD->SYAYS: Abolishes secretion. Strongly reduced
FT                   lysophospholipase activity."
FT                   /evidence="ECO:0000269|PubMed:21240271"
FT   CONFLICT        97
FT                   /note="A -> V (in Ref. 1; BAA05910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        107
FT                   /note="C -> S (in Ref. 1; BAA05910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        120
FT                   /note="S -> P (in Ref. 1; BAA05910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        147..162
FT                   /note="DCEEIKVPECPAGFVR -> AARNQSSECLQVCP (in Ref. 1;
FT                   BAA05910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        198
FT                   /note="A -> V (in Ref. 1; BAA05910)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        201
FT                   /note="M -> T (in Ref. 1; BAA05910)"
FT                   /evidence="ECO:0000305"
FT   TURN            59..63
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          69..72
FT                   /evidence="ECO:0007829|PDB:8C4W"
FT   TURN            77..83
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           89..92
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            98..100
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           104..106
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          107..109
FT                   /evidence="ECO:0007829|PDB:5L0K"
FT   STRAND          115..118
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           123..126
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           133..137
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           143..145
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          165..171
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           175..180
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            182..184
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           186..194
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          195..197
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           209..218
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           222..225
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          230..234
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            235..238
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          239..241
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          243..246
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           247..249
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           251..253
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           259..265
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           281..292
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            296..298
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          301..310
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           311..317
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          319..321
FT                   /evidence="ECO:0007829|PDB:7P4O"
FT   HELIX           322..324
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           325..344
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            348..350
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          352..358
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          368..371
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           372..374
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           379..381
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          382..385
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          387..395
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          396..398
FT                   /evidence="ECO:0007829|PDB:5L0B"
FT   HELIX           404..410
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          419..424
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           425..427
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           430..432
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          442..447
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          452..456
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           457..459
FT                   /evidence="ECO:0007829|PDB:7P4O"
FT   STRAND          462..465
FT                   /evidence="ECO:0007829|PDB:5S9M"
FT   STRAND          466..469
FT                   /evidence="ECO:0007829|PDB:7P4J"
FT   STRAND          471..473
FT                   /evidence="ECO:0007829|PDB:7P4O"
FT   HELIX           481..483
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          487..494
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          496..499
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           505..507
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           508..515
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            527..530
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           531..533
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          534..536
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           559..561
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           577..581
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            583..586
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            588..590
FT                   /evidence="ECO:0007829|PDB:5S9M"
FT   HELIX           617..620
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          634..638
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          643..647
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            648..651
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          652..660
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           671..673
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           685..687
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           691..696
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          701..706
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           708..710
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           714..717
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           718..721
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           723..725
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          726..729
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           731..742
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           744..752
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          754..762
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          768..770
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           774..776
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          790..801
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           806..808
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          813..821
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   TURN            830..833
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           836..838
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           840..846
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   HELIX           851..858
FT                   /evidence="ECO:0007829|PDB:5DLT"
FT   STRAND          859..861
FT                   /evidence="ECO:0007829|PDB:7P4J"
FT   STRAND          865..868
FT                   /evidence="ECO:0007829|PDB:7P4O"
FT   HELIX           870..878
FT                   /evidence="ECO:0007829|PDB:5DLT"
SQ   SEQUENCE   887 AA;  101576 MW;  40AD1C957F833869 CRC64;
     MARQGCLGSF QVISLFTFAI SVNICLGFTA SRIKRAEWDE GPPTVLSDSP WTNTSGSCKG
     RCFELQEVGP PDCRCDNLCK SYSSCCHDFD ELCLKTARGW ECTKDRCGEV RNEENACHCS
     EDCLSRGDCC TNYQVVCKGE SHWVDDDCEE IKVPECPAGF VRPPLIIFSV DGFRASYMKK
     GSKVMPNIEK LRSCGTHAPY MRPVYPTKTF PNLYTLATGL YPESHGIVGN SMYDPVFDAS
     FHLRGREKFN HRWWGGQPLW ITATKQGVRA GTFFWSVSIP HERRILTILQ WLSLPDNERP
     SVYAFYSEQP DFSGHKYGPF GPEMTNPLRE IDKTVGQLMD GLKQLRLHRC VNVIFVGDHG
     MEDVTCDRTE FLSNYLTNVD DITLVPGTLG RIRAKSINNS KYDPKTIIAN LTCKKPDQHF
     KPYMKQHLPK RLHYANNRRI EDIHLLVDRR WHVARKPLDV YKKPSGKCFF QGDHGFDNKV
     NSMQTVFVGY GPTFKYRTKV PPFENIELYN VMCDLLGLKP APNNGTHGSL NHLLRTNTFR
     PTMPDEVSRP NYPGIMYLQS EFDLGCTCDD KVEPKNKLEE LNKRLHTKGS TEAETGKFRG
     SKHENKKNLN GSVEPRKERH LLYGRPAVLY RTSYDILYHT DFESGYSEIF LMPLWTSYTI
     SKQAEVSSIP EHLTNCVRPD VRVSPGFSQN CLAYKNDKQM SYGFLFPPYL SSSPEAKYDA
     FLVTNMVPMY PAFKRVWAYF QRVLVKKYAS ERNGVNVISG PIFDYNYDGL RDTEDEIKQY
     VEGSSIPVPT HYYSIITSCL DFTQPADKCD GPLSVSSFIL PHRPDNDESC NSSEDESKWV
     EELMKMHTAR VRDIEHLTGL DFYRKTSRSY SEILTLKTYL HTYESEI
//
